Health And Medicine
-
Impulsivity in Parkinson’s Disease
A noninvasive MRI technique may help predict a troubling side effect of common medications for Parkinson’s Disease and improve clinical treatment plans. Read MoreOct 27, 2017
-
Vanderbilt leads international effort to develop universal flu vaccine
Researchers at Vanderbilt University Medical Center are leading an international effort to develop a universal influenza vaccine that would protect everyone against all strains of the flu anywhere in the world. Read MoreOct 26, 2017
-
Study seeks new ways to detect sensory issues in TBI patients
Vanderbilt researcher Tonia Rex, Ph.D., is accustomed to performing studies in her lab with a goal of translating the findings into better diagnoses and treatment tools for the visually impaired. Read MoreOct 26, 2017
-
Team to develop steerable robotic needle for biopsies
Collaboration between a mechanical engineer at Vanderbilt University and a pulmonologist at Vanderbilt University Medical Center (VUMC) has resulted in a National Institutes of Health (NIH) R01 grant that will be used to develop a steerable robotic needle to safely biopsy hard-to-reach lung nodules. Read MoreOct 26, 2017
-
Study to test combination therapy for breast cancer
Vanderbilt-Ingram Cancer Center (VICC) has received $2.3 million to fund a clinical research trial testing a combination of three immunotherapy compounds for patients with a specific type of advanced breast cancer. Read MoreOct 26, 2017
-
New faculty: Tuya Pal, associate professor of medicine and Ingram Associate Professor of Cancer Research
A high school science class discussion about how genetic traits are passed down from one generation to another inspired Tuya Pal to pursue a career in clinical genetics. Pal is a physician who specializes in cancer health disparities among diverse populations. Read MoreOct 26, 2017
-
New faculty: Renã A. S. Robinson, associate professor of chemistry
Renã A. S. Robinson’s interest in aging dates back to her childhood. Her mother spent her spare time as a caregiver attending to elderly people with dementia. Now an analytic chemist, Robinson is investigating the science behind this very human condition. She is employing the emerging field of proteomics to study the process of aging as well as neurodegenerative diseases like Alzheimer’s. Read MoreOct 23, 2017
-
New faculty: Erin Calipari, assistant professor of pharmacology
Erin Calipari could be described as a code breaker. Using technologies that allow her to probe the activity of single neurons in awake and behaving animals, she is piecing together the neural code that controls motivation and decision-making. Read MoreOct 23, 2017
-
Forum highlights strong clinical, translational research efforts
Clinical and translational research at Vanderbilt University Medical Center (VUMC) is thriving. Read MoreOct 19, 2017
-
Calcium intake and colorectal cancer
Calcium intake appears to protect against colorectal cancer in individuals with certain gene variants, Vanderbilt researchers have discovered. Read MoreOct 18, 2017
-
Gender, pain and dementia
Understanding sex differences in pain perception could lead to more targeted and effective pain assessment and management strategies in older adults with Alzheimer’s disease. Read MoreOct 16, 2017
-
New faculty: Mariann Piano, professor of nursing and senior associate dean for research
Four to five drinks in an evening. Starting the weekend on Thursday with happy hour. No big deal, right? Wrong, according to Mariann Piano, whose work indicates that binge drinking by young adults 18-30 may lead to vascular dysfunction and increased vulnerability to cardiovascular disease. Read MoreOct 16, 2017
-
New tools to combat kidney fibrosis
Vanderbilt investigators have developed a new mouse model of kidney fibrosis, which provides a platform for identifying new targets and treatment strategies. Read MoreOct 13, 2017
-
A switch for autoimmunity
Vanderbilt investigators have discovered a class of compounds that inhibit a mediator of inflammation and autoimmune disorders, and that could pave the way for development of future therapies. Read MoreOct 12, 2017
-
Researcher targets peanut allergies with Cohen Fund support
Scott Smith, M.D., Ph.D., assistant professor of Medicine, has received a 2017 research award from the Stanley Cohen Innovation Fund to test a new therapeutic strategy for peanut allergies. Smith's research could fundamentally change allergy treatment. Read MoreOct 12, 2017
-
VIGH receives federal grants to fight kidney disease
Researchers in the Vanderbilt Institute for Global Health (VIGH) have received two new grants from the National Institutes of Health (NIH) aimed at reducing the risk of kidney disease in HIV-infected adults and improving the treatment of epilepsy in children in Nigeria. Read MoreOct 12, 2017
-
Major international study testing therapy to prevent spread of HIV
Nine more volunteers are needed to complete a study at Vanderbilt University Medical Center (VUMC) that could lead to a way to prevent the spread of HIV (human immunodeficiency virus). Read MoreOct 5, 2017
-
Mayor to speak at Center for Addiction Research science day
Nashville Mayor Megan Barry will speak during a “science day,” Tuesday, Oct. 17, at the Belcourt Theatre hosted by the Vanderbilt Center for Addiction Research (VCAR). Read MoreOct 5, 2017
-
Boosting sarcoma cell death
A compound identified at Vanderbilt represents a new lead for treating rare, aggressive childhood cancers called Ewing sarcomas. Read MoreOct 4, 2017
-
Cell signals that trigger wound healing are surprisingly complex
Vanderbilt scientists have taken an important step toward understanding the way in which injured cells trigger wound healing, an insight essential for improving treatments of all types of wounds. Read MoreOct 3, 2017